Publications (121)

2022

  1. The Role of Perceived Utility of Full Health in Age Weighting

    Value in Health, Vol. 25, Núm. 9, pp. 1559-1565

  2. Reference-dependent age weighting of quality-adjusted life years

    Health Economics (United Kingdom), Vol. 31, Núm. 12, pp. 2515-2536

  3. QALY Maximization and the Social Optimum

    Hacienda Pública Española / Review of Public Economics, Núm. 242, pp. 111-127

2021

  1. The value of statistical life in the context of road safety: new evidence on the contingent valuation/standard gamble chained approach

    Journal of Risk and Uncertainty, Vol. 63, Núm. 2, pp. 203-228

2020

  1. What is an efficient health intervention in Spain in 2020?

    Gaceta Sanitaria, Vol. 34, Núm. 2, pp. 189-193

  2. The societal monetary value of a QALY associated with EQ-5D-3L health gains

    European Journal of Health Economics, Vol. 21, Núm. 3, pp. 363-379

  3. Exploring the relative value of end of life QALYs: Are the comparators important?

    Social Science and Medicine, Vol. 245

2019

  1. Sequence effects in time trade-off valuation of hypothetical health states

    Health Economics (United Kingdom), Vol. 28, Núm. 11, pp. 1308-1319

  2. Eliciting Health State Utilities Using Paired-Gamble Methods: The Role of the Starting Point

    Value in Health, Vol. 22, Núm. 4, pp. 446-452

  3. Do time trade-off values fully capture attitudes that are relevant to health-related choices?

    European Journal of Health Economics, Vol. 20, Núm. 4, pp. 559-568

2018

  1. Reducing preference reversals: The role of preference imprecision and nontransparent methods

    Health Economics (United Kingdom), Vol. 27, Núm. 8, pp. 1230-1246

  2. Peer effects in health valuation: The relation between rating of contemporaries' health and own health

    Health and Quality of Life Outcomes, Vol. 16, Núm. 1

  3. Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach

    Value in Health, Vol. 21, Núm. 5, pp. 596-604

  4. Emotions and scope effects in the monetary valuation of health

    European Journal of Health Economics, Vol. 19, Núm. 3, pp. 315-325

2017

  1. Evaluación económica y análisis de decisiones

    Conceptos de salud pública y estrategias preventivas: un manual para ciencias de la salud (Elsevier), pp. 73-77

  2. Risk attitudes in medical decisions for others: An experimental approach

    Health Economics (United Kingdom), Vol. 26, pp. 97-113

  3. Improving scope sensitivity in contingent valuation: Joint and separate evaluation of health states

    Health Economics (United Kingdom), Vol. 26, Núm. 12, pp. e304-e318

  4. Exploring Differences between TTO and DCE in the Valuation of Health States

    Medical Decision Making, Vol. 37, Núm. 3, pp. 273-284

  5. Age effects in mortality risk valuation

    European Journal of Health Economics, Vol. 18, Núm. 7, pp. 921-932

  6. Adverse events from systemic treatment of cancer and patient-reported quality of life

    Journal of Community and Supportive Oncology, Vol. 15, Núm. 5, pp. e256-e262